SCHEMBL29948313

SCHEMBL29948313

CS(=O)(=O)c1ccc(N)c(Br)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 9/20 0.70
CA1 P00915 8/20 0.70
CA9 Q16790 8/20 0.70
CA12 O43570 5/20 0.70
CA4 P22748 4/20 0.70
CA6 P23280 4/20 0.70
CA5A P35218 4/20 0.70
CA7 P43166 4/20 0.70
CA14 Q9ULX7 4/20 0.70
CA5B Q9Y2D0 4/20 0.70
G6PD P11413 1/20 0.58
IDE P14735 1/20 0.58
CA3 P07451 1/20 0.43
PKM P14618 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10694524 1.00 CA2 (0.70) CA2CA1CA9CA12CA4
SCHEMBL1006804 0.83 G6PD (0.53) CA2CA1CA9CA12CA4
SCHEMBL878968 0.83 CA2 (1.00) CA2CA1CA9CA12CA4
SCHEMBL2811342 0.83 CA2 (0.76) CA2CA1CA9CA12CA4
SCHEMBL30351262 0.83 CA2 (1.00) CA2CA1CA9CA12CA4
SCHEMBL4639254 0.81 G6PD (0.60) CA2CA1CA9CA12CA4
SCHEMBL898422 0.80 G6PD (0.64) CA2CA1CA9CA12CA4
SCHEMBL10688819 0.80 CA2 (0.66) CA2CA1CA9CA12CA4
SCHEMBL3434572 0.79 CA2 (0.70) CA2CA1CA9CA12CA4
SCHEMBL7769757 0.79 CA2 (0.70) CA2CA1CA9CA12CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4134364-B1 BROMODOMAIN INHIBITORS CELGENE QUANTICEL RES INC (US) 2025-07-30 EP disclosed
EP-4384510-A1 COMPOUNDS TARGETING MUTANT OF P53 Jacobio Pharmaceuticals Co., Ltd. (CN) 2024-06-19 EP disclosed
CN-117813295-A Compounds targeting p53 mutants 北京加科思新药研发有限公司 2024-04-02 CN disclosed
WO-2023016434-A1 COMPOUNDS TARGETING MUTANT OF P53 JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2023-02-16 WO disclosed
EP-4134364-A2 BROMODOMAIN INHIBITORS Celgene Quanticel Research, Inc. (US) 2023-02-15 EP disclosed
EP-3640241-B1 BROMODOMAIN INHIBITORS CELGENE QUANTICEL RES INC (US) 2022-09-28 EP disclosed